Bastide le Confort (BLC) | Financial Analysis & Statements
Bastide le Confort Médical S.A. | Mid-cap | Healthcare
Bastide le Confort Médical S.A. | Mid-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
529.8M
Gross Profit
354.4M
66.91%
Operating Income
44.2M
8.35%
Net Income
1.2M
0.23%
EPS (Diluted)
-€0.12
Balance Sheet Metrics
Total Assets
647.1M
Total Liabilities
566.3M
Shareholders Equity
80.7M
Debt to Equity
7.02
Cash Flow Metrics
Operating Cash Flow
34.4M
Free Cash Flow
37.3M
Revenue & Profitability Trend
Bastide le Confort Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 529.8M | 508.0M | 468.3M | 444.1M | 382.7M |
| Cost of Goods Sold | 175.3M | 174.3M | 161.5M | 163.8M | 131.1M |
| Gross Profit | 354.4M | 333.7M | 306.8M | 280.3M | 251.6M |
| Operating Expenses | 89.2M | 86.1M | 155.9M | 144.1M | 131.1M |
| Operating Income | 44.2M | 42.0M | 38.4M | 37.5M | 33.7M |
| Pre-tax Income | 16.5M | 22.8M | 21.0M | 20.2M | 20.3M |
| Income Tax | 7.0M | 6.0M | 5.9M | 5.8M | 7.7M |
| Net Income | 1.2M | 12.8M | 14.3M | 14.3M | 12.6M |
| EPS (Diluted) | -€0.12 | €1.52 | €1.86 | €1.83 | €1.58 |
Income Statement Trend
Bastide le Confort Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 208.9M | 196.4M | 186.6M | 164.1M | 171.9M |
| Non-Current Assets | 438.1M | 460.7M | 445.9M | 405.0M | 334.1M |
| Total Assets | 647.1M | 657.1M | 632.6M | 569.1M | 506.0M |
| Liabilities | |||||
| Current Liabilities | 216.2M | 225.0M | 175.0M | 147.9M | 142.9M |
| Non-Current Liabilities | 350.1M | 344.0M | 370.9M | 336.1M | 283.5M |
| Total Liabilities | 566.3M | 569.0M | 545.9M | 484.1M | 426.4M |
| Equity | |||||
| Total Shareholders Equity | 80.7M | 88.1M | 86.7M | 85.1M | 79.6M |
Balance Sheet Composition
Bastide le Confort Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 1.2M | 12.7M | 14.3M | 14.3M | 12.6M |
| Operating Cash Flow | 34.4M | 31.1M | 25.6M | 26.5M | 20.2M |
| Investing Activities | |||||
| Capital Expenditures | -51.3M | -52.8M | -50.6M | -45.9M | -39.0M |
| Investing Cash Flow | -42.8M | -75.9M | -104.5M | -73.2M | -51.1M |
| Financing Activities | |||||
| Dividends Paid | -1.6M | -613.0K | -2.4M | -2.1M | -69.0K |
| Financing Cash Flow | -15.0M | 21.7M | 54.9M | 25.4M | 41.2M |
| Free Cash Flow | 37.3M | 52.0M | 3.6M | 27.8M | 7.5M |
Cash Flow Trend
Bastide le Confort Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
26.34
Forward P/E
10.08
Price to Book
2.98
Price to Sales
0.41
PEG Ratio
10.08
Profitability Ratios
Profit Margin
0.32%
Operating Margin
9.53%
Return on Equity
10.46%
Return on Assets
4.53%
Financial Health
Current Ratio
1.19
Debt to Equity
541.81
Beta
0.86
Per Share Data
EPS (TTM)
€1.16
Book Value per Share
€10.26
Revenue per Share
€72.38
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| blc | 223.2M | 26.34 | 2.98 | 10.46% | 0.32% | 541.81 |
| Laboratoires | 12.0M | 28.13 | 0.73 | -31.26% | -16.78% | 48.76 |
| Metrics In Balance | 790.3K | - | 0.01 | -0.45% | -17,317.00% | - |
| bioMérieux S.A | 14.2B | 32.96 | 3.37 | 10.68% | 10.86% | 11.65 |
| Eurofins Scientific | 10.6B | 28.48 | 2.56 | 7.71% | 5.85% | 67.05 |
| Ipsen S.A | 8.4B | 23.61 | 1.99 | 8.93% | 9.68% | 12.33 |
Financial data is updated regularly. All figures are in the company's reporting currency.